AZD1208: Clinical Trials

2 trials of AZD1208, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1

Follow AZD1208: new trials by email Literature Review of AZD1208 trials Research Report on AZD1208

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma
AZD1208 - Advanced Solid Malignancies, Malignant Lymphoma
Phase 1CompletedAstraZeneca432012-07-012015-11-04
Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
AZD1208 - Acute Myeloid Leukemia
Phase 1TerminatedAstraZeneca552012-02-012015-08-11

Conditions studied

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma (1)

Sponsors

AstraZeneca (2)

Countries

Canada (1)  ·  Japan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Frank Neumann, MD (1)  ·  Frank Neumann, MSD (1)